Search for Clinical Trial Results

Sponsored By

Hypereosinophilic Syndrome - 14 Studies Found

Status Study
Terminated Study Name: A Study to Determine the Safety and Efficacy of Imatinib Mesylate in Patients With Idiopathic Hypereosinophilic Syndrome
Condition: Hypereosinophilic Syndrome
Date: 2005-09-13
Interventions: Drug: imatinib mesylate Other Name: Gleevec/Glivec
Terminated Study Name: Open-Label Extension Of Intravenous Mepolizumab In Patients With Hypereosinophilic Syndrome
Condition: Hypereosinophilic Syndrome
Date: 2004-11-22
Interventions: Drug: mepolizumab Study Drug
Completed Study Name: Efficacy and Safety Study of Mepolizumab in Subjects With Severe Hypereosinophilic Syndrome (HES)
Condition: Hypereosinophilic Syndrome
Date: 2016-07-14
Interventions:
  • Drug: Mepolizumab 300 mg Mepol
Active, not recruiting Study Name: Identification of New Markers in the Hypereosinophilic Syndrome
Condition: Hypereosinophilic Syndrome
Date: 2012-10-22
Interventions: Biological: biologie sample comparison of biomarkers between HES, HE biomarkers data and control arms
Active, not recruiting Study Name: Study to Evaluate Safety and Efficacy of Dexpramipexole (KNS-760704) in Subjects With Hypereosinophilic Syndrome
Condition: Hypereosinophilic Syndrome
Date: 2014-03-14
Interventions: Drug: Dexpramipexole Dexpramipexole (KNS 760704) is a synthetic amino-benzothiazole developed for use in
Completed Study Name: Intravenous Mepolizumab In Subjects With Hypereosinophilic Syndromes (HES)
Condition:
  • Hypereosinophilia
  • Hypereosinophilic Syndrome

Date: 2004-07-07
Interventions: Drug: mepolizumab
Available Study Name: This Record Contains Information About the Mepolizumab Compassionate Use Product Activities: 104317: An Open-Label Compassionate Use and Long-Term Access Study of Mepolizumab in HES 201956: A Long-term Access Programme for Subjects With Severe Asthma
Condition: Hypereosinophilic Syndrome
Date: 2005-10-25
Interventions: Drug: Mepolizumab open label investigational product
Completed Study Name: Efficacy of Imatinib Mesylate in Hypereosinophilic Syndromes
Condition:
  • Hypereosinophilic Syndrome
  • Chronic Eosinophilic Leukemia
    • <
    Date: 2008-11-06
    Interventions: Drug: Imatinib Patients received oral imatinib 100 mg/d; in case of unsatisfactory response (less than c
Completed Study Name: Study of STI571 in the Treatment of Patients With Idiopathic Hypereosinophilic Syndrome (HES) and Eosinophilic Leukemias
Condition:
  • Hypereosinophilic Syndrome
  • Chronic Eosinophilic Leukemia (CEL)<
    Date: 2006-01-12
    Interventions: Drug: STI571
Completed Study Name: Steroid Treatment for Hypereosinophilic Syndrome
Condition: Hypereosinophilia
Date: 2012-02-01
Interventions: Drug: Corticosteroids
Next >>>